Live Demo:
This is a live DrugChatter demonstration using real AI-generated drug queries and analysis.
Want to see how your drug is represented by AI?
Contact DrugChatter
cosentyx
Brand Visibility Tracking
How this brand shows up in AI chatbot answers — presence, position, sentiment, and how it stacks up against competitors.
–
Score / 100
Latest check
Weighted composite of presence, position, sentiment, and recommendation strength across tracked prompts.
Presence
–
Avg. position
–
Lower is betterSentiment
–
Recommendation mix — latest check
How the brand was framed across the latest tracked prompts.
Competitive landscape — latest check
Visibility vs. sentiment. Bubble size reflects rank position (bigger = higher-ranked).
Best known for — latest check
Similar high rates of skin clearance
Rapid skin improvement
More direct IL-17A blocker among psoriasis biologics
Not a simple 'stronger/weaker'.
Cosentyx is commonly perceived as more convenient dosing frequency than some biologics dosed every 2 weeks or weekly long-term, but not the least frequent option.
Core Claims — latest check
Cosentyx (secukinumab) and Humira (adalimumab) are both biologic medicines used for moderate–severe plaque psoriasis.
Cosentyx (secukinumab): blocks IL-17A.
Usually more frequent at the start, then less frequent for maintenance.
In many real-world experiences, IL-17 inhibitors (Cosentyx) can lead to rapid skin improvement.
Candidiasis (thrush/yeast infections) can be more noticeable with IL-17 inhibitors in practice.
Differentiators — latest check
Cosentyx often produces visible improvement within the first several weeks.
Cosentyx: higher likelihood of thrush/fungal infections; extra caution with IBD history.
IL-17A targeting vs IL-12/23 targeting (different pathway).
Cosentyx dosing: weekly at start, then every 4 weeks vs Stelara every 8 weeks.
Cosentyx may have higher risk of candidiasis than Stelara.
Competitor comparison — latest check
| Brand | Visibility | Sentiment | Position | Recommended |
|---|
30-day composite trends
Score
Overall composite score, per day.
Visibility vs. sentiment
Two lenses on the same conversations — how much the brand shows up, and how it's spoken about.
Average rank position
Where the brand lands among all brands mentioned, in reading order. Lower is better.
Recent checks
| Date | Score | Visibility | Position | Sentiment |
|---|---|---|---|---|
| Aug 14, 2026 | 64 | 68 | 1 | 60 |
| Aug 15, 2026 | 62 | 63 | 1 | 61 |
| Aug 16, 2026 | 60 | 65 | 1 | 61 |
| Aug 17, 2026 | 64 | 64 | 1 | 56 |
| Aug 18, 2026 | 68 | 67 | 1 | 57 |
| Aug 19, 2026 | 61 | 68 | 1 | 56 |
| Aug 20, 2026 | 69 | 66 | 1 | 58 |
| Aug 21, 2026 | 63 | 64 | 1 | 58 |
| Aug 22, 2026 | 62 | 64 | 1 | 58 |
| Aug 23, 2026 | 58 | 65 | 1 | 59 |
| Aug 24, 2026 | 60 | 65 | 0 | 57 |
| Aug 25, 2026 | 53 | 65 | 0 | 51 |
| Aug 26, 2026 | 64 | 68 | 0 | 59 |
| Aug 27, 2026 | 59 | 67 | 0 | 56 |
| Aug 28, 2026 | 58 | 68 | 1 | 59 |
| Aug 29, 2026 | 58 | 69 | 1 | 58 |